David L. Brinkley, Head of Business Development at THERAVANCE INC (THRX), sold 123,917 shares at $27.92 ($3.5M) on 2012-08-03, disclosed to the SEC on 2012-08-07.
Scheduled sale ($3.5M) by Head of Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| THRX | SELL | 2013-05-07 | $561K | — | Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |